Lobbying Relationship

Client

Tauzin Consultants (on behalf of Scilex Holding Company)

More records

Lobbying firm

Tauzin Strategic Networks

More records

  • Healthcare, Medicare (specific issues related to fair competition, the generic drug market, drug costs, pain management, COVID)

Duration: to

General Issues: Health Issues, Medicare/Medicaid

Spending: about $210,000 (But it's complicated. Here's why.)

Agencies lobbied since 2019: U.S. Senate, House of Representatives

Affiliated organizations: Scilex Holding Company; Scilex Pharmaceuticals Inc.; Semnur Pharmaceuticals Inc

Bills mentioned

S.1895: Lower Health Care Costs Act

Sponsor: Lamar Alexander (R-Tenn.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
W.J. "Billy" Tauzin II Member of Congress (LA-3)
W.J. "Billy" Tauzin Member of Congress (LA-3)

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Registration
Amendment
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page